Brief: Abionyx Pharma: Cash Position of EUR 4.0 Mln As Of June 30

Abionyx Pharma SA

18/08/2022 16:48

Aug 18 (Reuters) - Abionyx Pharma SA  ABNX.PA :
    * PROVIDES AN UPDATE ON ITS BUSINESS AND CASH POSITION FOR
FIRST
HALF OF 2022
    * CASH OF EUR 4.0 MILLION (EXCLUDING RESEARCH TAX CREDIT) AS
OF
JUNE 30, 2022
    * COMPANY RECORDED A CONSOLIDATED HALF-YEARLY TURNOVER OF
EUR
2,630K, AFTER ELIMINATION OF INTRA-GROUP TRANSACTIONS
    * PHASE 2A CLINICAL TRIAL FOR CER-001: FINAL STUDY RESULTS
TO BE
AVAILABLE IN FALL 2022

Source text for Eikon:  ID:nBw29gKl4a 
Further company coverage:  ABNX.PA 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))